Page 32 - Sohini Das

Loss of patents: Indian pharma companies gain, shows PharmaTrac data

While MNCs posted a 5 per cent five-year compound annual growth rate (CAGR) in the chronic segment, Indian pharma companies have recorded a 9 per cent 5-year CAGR

No M pneumoniae cases in samples tested since Jan in India: Health ministry

Mycoplasma pneumoniae, a bacteria, is linked to the surge in children's hospitalisation in China

DRL partners with Coya Therapeutics to develop nerve disorder therapy

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurological disorder characterised by progressive degeneration of nerve cells in the spinal cord and brain

Manipal Health Enterprises may soon become India's largest hospital chain

Temasek plans to subsume Medica Synergie into Manipal next year

Top gear: Two-wheelers lead the line for auto festival sales this year

The Federation of Automobile Dealers Associations (FADA) data showed a 19 per cent growth in auto sales during the 42-day festival period in 2023

Higher production, festival season drive domestic car sales in November

Companies like MSIL and Tata Motors have announced price increases from January 1

Experts warn of Covid spike in Kerala as vaccine-induced immunity wanes

Kerala now has 194 active cases, accounting for 61 per cent of the active cases in India

Indian states' health departments on alert as China pneumonia cases spike

Union health ministry advised states to immediately review preparedness

Pharma exports may return to double digit-growth rate: Pharmexcil

Drug shortages in US and EU, revival in Africa key drivers

Aster DM Healthcare sells stake in Gulf business for $1.01 billion

Aster to separate its India and GCC businesses to unlock value

From budget to luxury, cars to get more expensive from January 2024

Maruti, Tata, M&M, Audi cite cost pressure for pushing up prices

Audi India raises prices of vehicles by 2% from Jan 1 on rising input costs

Audi India registered an 88 per cent growth and has retailed 5,530 units in the first nine months of this year

Pharma majors turn attention to OTC drugs in post-pandemic wellness shift

Building a healthy OTC brand, however, is not an easy task. OTC brands need time to grow and build a recall value once they have established some credibility

M&M Q2FY24 results: Profit hits brakes; consolidated net down 15%

On a sequential basis, the company's net profit declined 33 per cent from Rs 3,508 crore in the previous quarter, while it posted a 1.6 per cent rise in revenue from operations

PV wholesales touch all-time high for October even as car sales dip

The growth of the Passenger Vehicle (PV) segment is coming from the utility vehicles which clocked a Y-o-Y growth of 40 per cent to 198,356 units in October

Apollo Hospitals Q2 profit up 14% to Rs 4,846.9 cr on better patient flows

Apollo looking for another Greenfield hospital in Mumbai is not reported

Lupin's net profit jumps nearly four-fold on strong US growth, stock up

US sales cross $200 million for the first time in two years, beat analyst expectations

Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr

The agreement is for more than 20 brands that earned Rs 90 crore as revenue in FY23 and have a run rate of around Rs 100 crore

Automobile dealers flag 'distress' if Diwali sales fail to dazzle

The country's largest passenger car maker Maruti Suzuki India (MSIL) agreed that inventory levels are inching up in some models

Should touch Rs 1K crore from OTC this year, says Nandini Piramal

In an interview with Sohini Das, Piramal Pharma Chairperson Nandini Piramal outlines her plans, and why she wants to focus on profitability